On March 14, 2025, the Food and Drug Administration (FDA) announced a voluntary recall of several acne treatments due to elevated levels of benzene, a known carcinogen. The affected products include brands like Walgreens, Proactiv, and La Roche-Posay, which were found to have higher than acceptable benzene levels during FDA testing.
- FDA recalls acne treatments for benzene levels
- Products from Walgreens, Proactiv, La-Roche Posay
- Retailer recalls, not consumer recalls
- Low cancer risk from these products
- Benzene exposure can disrupt cell function
- Symptoms of benzene poisoning vary widely
The FDA’s findings resulted from tests on 95 products containing benzoyl peroxide, a common acne treatment ingredient. Six products were identified for recall, prompting retailers to remove them from shelves.
The FDA identified six acne treatment products with concerning levels of benzene, which can occur as a byproduct of benzoyl peroxide. The recalled products are:
- La Roche-Posay Effaclar Duo Dual Action Acne Treatment (lot MYX46W, exp. April 2025)
- Walgreens Acne Control Cleanser (lot 23 09328, exp. September 2025)
- Proactiv Emergency Blemish Relief Cream (lot V3305A and V3304A, exp. October 2025)
- Proactiv Skin Smoothing Exfoliator (lot V4204A, exp. July 2025)
- SLMD Benzoyl Peroxide Acne Lotion (lot 2430600, exp. March 2025)
- Walgreens Tinted Acne Treatment Cream (lot 49707430, exp. March 2026)
While the FDA’s recall is directed at retailers, consumers who have purchased these products are not required to take immediate action. However, the FDA recommends disposing of any expired products. The agency reassures that the risk of developing cancer from these treatments is very low, even for long-term users.
Benzene is a chemical found in various natural and industrial sources, including gasoline and cigarette smoke. Long-term exposure can lead to serious health issues, including a weakened immune system and increased cancer risk. Symptoms of benzene exposure can include headaches, irregular heartbeat, and more severe effects if ingested.
The FDA’s recall of these acne treatments highlights ongoing concerns about product safety and consumer health. As further testing results are expected in the coming months, consumers are encouraged to stay informed about the products they use.